SecBot SecBot
144 ·Filed Nov 9, 2026

RMD

RESMED INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed7d 6h ago SEC0001959173-26-007872
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small relative to market cap and follows a pattern of monthly option-exercise-and-sell transactions by this insider. No material signal for the stock; monitor for any change in the cadence or size of insider sales.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$234.11
T+0 close · Nov 9, 2026 · via day close
Latest settled
+1.89%
T+1 · $238.53
Vs SPY
+0.57%
α at T+1
Next horizon
T+5
in 8h
  1. T+0 · Nov 10 $234.11entry
  2. T+1 · 6d ago +1.89%α +0.57% · $238.53
  3. T+4 · todayOpen
  4. T+5 · in 8h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Michael J. Farrell, an officer and director of ResMed, filed a Form 144 notice of intent to sell 4,993 shares of common stock with an approximate market value of $1.175 million. The shares were acquired through a stock option exercise on the same day, and the sale is planned for execution on the NYSE.

Key Facts

  • Michael J. Farrell (Officer and Director) filed Form 144 to sell 4,993 shares
  • Estimated aggregate market value of the proposed sale: $1,175,089.20
  • Shares were acquired via stock option exercise on 11/09/2026
  • Proposed sale date: 11/09/2026
  • Broker: Fidelity Brokerage Services LLC
  • Farrell's most recent prior sales: 4,991 shares on 09/08/2026 and 4,991 shares on 10/07/2026

Financial Impact

Proposed sale of 4,993 shares valued at approximately $1.175 million, representing about 0.0035% of ResMed's $33.7B market cap

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur
  • Insider selling pattern is routine and does not indicate a change in outlook

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
52% bullish (27 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007872
Document: 0001959173-26-007872-index.html0001959173-26-007872
Document: 0001959173-26-007872.txt0001959173-26-007872

Track record

19 reports on RMD

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +28.97% at T+60 after the Jun 1, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $234.11 Now $238.19 +1.74% settles Dec 9
  2. Oct 29, 202618d ago 8-K Bullish 6/10 No price data
  3. Oct 29, 202618d ago Press Release Bullish 6/10 Entry $229.94 Now $238.19 +3.59% settles Nov 30
  4. Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $238.88 to $238.19 Now $238.19 +0.29% ▲ +0.29% −3.17% vs SPY
  5. Oct 7, 20265w ago 144 Neutral 3/10 Entry $226.73 to $240.51 Now $238.19 +5.05% ▲ +6.08% +11.37% vs SPY
  6. Oct 1, 20266w ago DEFA14A Neutral 2/10 Entry $218.89 to $229.94 Now $238.19 +8.82% ▲ +5.05% +6.86% vs SPY
  7. Oct 1, 20266w ago DEF 14A Neutral 4/10 Entry $218.89 to $252.83 Now $238.19 +8.82% ▲ +15.51% +17.31% vs SPY
  8. Oct 1, 20266w ago Press Release Neutral 1/10 Entry $218.89 Now $238.19 +8.82% No price data
  9. Sep 10, 20269w ago Insider Cluster Neutral 4/10 Entry $219.58 to $226.73 Now $238.19 +8.48% ▲ +3.26% +1.13% vs SPY
  10. Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $224.84 to $219.95 Now $238.19 +5.94% ▼ −2.17% −1.12% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens Wed (10h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026